← brief for 2026-09-17 · Slowing decline

Redefining weight management after liver transplantation with glucagon-like peptide one and gastric inhibitory polypeptide receptor agonists.

Paper No results yet Peer reviewed

Key takeaways

This review discusses using weight loss drugs to help people after liver transplants. It looks at how these drugs might protect the kidneys and prevent diabetes. It is a summary of existing evidence, not a new trial with fresh results.

Who did this work

Elatrebi S · Abuyadek R · Abdelbar SMM · Ahmad MS · Ayyad M · Quoritem MA · Abdel Majid RO · Arafat M · Amgad A · Alnagar A

Source

Paper · PubMed, the drug frontier · 2026 Sep 18
https://pubmed.ncbi.nlm.nih.gov/42751234/